Plaque psoriasis patients with lower blood monocyte counts at baseline achieved early response when treated with secukinumab.

Guselkumab has shown improvements in skin clearance, scalp itch, and patient-report health-related QoL in skin of colour patients.

IL-23 inhibitors used to treat psoriasis patients are associated with the lowest risk of paradoxical AD compared to other biologics.

A lack of published psoriasis images complicates communication with patients, according to a study from the University of Gothenburg,...

Psoriasis patients with pruritis and related sleep distrubances showed a lower quality of life in all domains.

Researchers developed a PRESTO tool using clinical variables to predict PsA risk in PsO patients with reasonable accuracy.

Roflumilast showed significant improvement in disease severity in 95% of plaque psoriasis patients by week 8.

Psoriasis is not caused or spread by spontaneous genetic mutations in the skin, new research suggests. These findings come from a study...